Skip to Content

ZA47 (Divalproex Sodium Extended-Release 250 mg)

Pill with imprint ZA47 is White, Capsule-shape and has been identified as Divalproex Sodium Extended-Release 250 mg. It is supplied by BluePoint Laboratories.

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; cyclothymic disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA47

Divalproex Sodium Extended-Release

Imprint:
ZA47
Strength:
250 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
BluePoint Laboratories
National Drug Code (NDC):
68001-0105

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide